scholarly journals Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins

2020 ◽  
pp. 88-104
Author(s):  
M. A. Kachkovsky ◽  
I. P. Vvedenskaya ◽  
V. Yu. Vvedensky ◽  
A. A. Supilnikov ◽  
J. V. Ponomareva ◽  
...  
Keyword(s):  
Lipid Metabolism ◽  
Cardiovascular Diseases ◽  
Genetic Polymorphisms ◽  
Clinical Recommendations ◽  
Treatment And Prevention ◽  
Target Values ◽  
Prevention And Treatment ◽  
Protein Components

Many questions remain in the diagnosis, treatment, and prevention of dyslipidemia, despite the available clinical recommendations. Among these issues is the cause of cardiovascular diseases, when achieving and maintaining the target values of lipid metabolism. We need to change the existing paradigm. Apolipoproteins as protein components of lipoproteins can significantly more accurately characterize the dyslipidemic status of a patient, since their structure and composition are unique. A personalized strategy for the prevention and treatment of dyslipidemia is possible based on the apolipoprotein profile. At present, new data on the functions of apolipoproteins, their genetic polymorphisms, and molecular preparations for correcting their content and lipid metabolism have been proposed.

scholarly journals The prevalence of acute erosive-ulcerative gastroduodenal lesions in patients with cardiovascular diseases, taking anticoagulants and antiplatelet agents

2020 ◽  
pp. 65-74
Author(s):  
A. A. Poliantsev ◽  
D. V. Frolov ◽  
D. V. Linchenko ◽  
S. N. Karpenko ◽  
A. A. Chernovolenko ◽  
...  
Keyword(s):  
Cardiovascular Diseases ◽  
Clinical Manifestations ◽  
Antiplatelet Agents ◽  
Individual Characteristics ◽  
Risk Of Bleeding ◽  
Treatment And Prevention ◽  
Prevention And Treatment ◽  
The Individual ◽  
Methods Of Treatment ◽  
Upper Gastrointestinal

Aims: to draw attention to the lack of recommendations for the prevention and treatment of acute erosive-ulcerative gastroduodenal lesions and their complications associated with the severity of the patient’s condition, the massiveness of antiplatelet and anticoagulant therapy and the degree of risk of bleeding.Materials and methods: a literature review was conducted of domestic and foreign authors on the problem of pathogenesis, clinical manifestations, diagnosis, treatment and prevention of lesions of the upper gastrointestinal tract in cardiovascular diseases.Results: there are no standardized recommendations for the prevention and treatment of OEGP and their complications, taking into account the individual characteristics of the patient, based on evidence.Conclusion: it is necessary to develop a scale that assesses the risk of OEGP and gastrointestinal bleeding in cardiovascular diseases, methods of treatment and prevention of these conditions, taking into account the specific parameters of the patient.

Civilization stress, cardiovascular risk, evidence based medicine, guideline

2009 ◽  
Vol 150 (19) ◽  
pp. 895-902 ◽  
Author(s):  
Kornél Simon
Keyword(s):  
Cardiovascular Risk ◽  
Cardiovascular Diseases ◽  
Chronic Stress ◽  
Randomized Clinical Trials ◽  
Decisive Role ◽  
Profit Sharing ◽  
Pole Position ◽  
Ethical Question ◽  
Drug Sale ◽  
Target Values

Cardiovascular diseases have the pole-position on the list of morbidity and mortality statistics. Despite the great advances have been made in management of cardiovascular diseases, prevalence of these disorders increases worldwide, and even younger and younger ages are threatened. This phenomenon is strongly related to obesity and type 2 diabetes pandemic, which shows an unequivocal association with expansion of modernized life-style. The pathomechanism proposed to have central role is the chronic stress induced by civilized life-conduct. The authors criticizes the everyday practice suggested for management of cardiovascular diseases, focusing on normalization of cardiovascular risk factors, instead of fighting against the primary cause ie. chronic stress. There is growing evidence, that achieving the target values defined in guide-lines will not necessarily result in improvement of patient related clinical outcomes. The statistical approach generally practiced in randomized clinical trials is primarily striving for the drug-sale, instead of discovering novel pathophysiological relations. Pharmaceutical industry having decisive role in research and patient-care is mainly interested in profit-sharing, therefore patients’ interest can not be optimally realized, and costs are unnecessarily augmented. Separation of patient-, and business-oriented medical care is an ethical question of fundamental importance.

Nanoparticles and Its Implications in HIV/AIDS Therapy

2020 ◽  
Vol 17 (4) ◽  
pp. 448-456 ◽  
Author(s):  
Victor B. Oti
Keyword(s):  
Direct Injection ◽  
Oral Intake ◽  
Public Health Problem ◽  
Antiretroviral Drugs ◽  
The Body ◽  
Viral Agent ◽  
Treatment And Prevention ◽  
Prevention And Treatment ◽  
Hiv Aids

The use of Antiretroviral drugs in treating HIV/ AIDS patients has enormously increased their life spans with serious disadvantages. The virus infection still remains a public health problem worldwide with no cure and vaccine for the viral agent until now. The use of nanoparticles (NPs) for the treatment and prevention of HIV/AIDS is an emerging technology of the 21st century. NPs are solid and colloid particles with 10 nm to <1000 nm size range; although, less than 200 nm is the recommended size for nanomedical usage. There are NPs with therapeutic capabilities such as liposomes, micelles, dendrimers and nanocapsules. The particle enters the body mainly via oral intake, direct injection and inhalation. It has been proven to have potentials of advancing the prevention and treatment of the viral agent. Certain NPs have been shown to have selftherapeutic activity for the virus in vitro. Strategies that are novel are emerging which can be used to improve nanotechnology, such as genetic treatment and immunotherapy. In this review, nanoparticles, the types and its characteristics in drug delivery were discussed. The light was furthermore shed on its implications in the prevention and treatment of HIV/AIDS.

scholarly journals Prevention and Treatment of Phlebitis Secondary to the Insertion of a Peripheral Venous Catheter: A Scoping Review from a Nursing Perspective

Healthcare ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 611
Author(s):  
Aitana Guanche-Sicilia ◽  
María Sánchez-Gómez ◽  
María Castro-Peraza ◽  
José Rodríguez-Gómez ◽  
Juan Gómez-Salgado ◽  
...  
Keyword(s):  
Venous Catheter ◽  
Venous Access ◽  
Medication Administration ◽  
Volume Control ◽  
Nursing Interventions ◽  
Intravenous Therapy ◽  
Treatment Protocols ◽  
Peripheral Venous Catheter ◽  
Treatment And Prevention ◽  
Prevention And Treatment

The objective of this work was to identify available evidence on nursing interventions for the prevention and treatment of phlebitis secondary to the insertion of a peripheral venous catheter. For this, a scoping systematic review was carried out following the guidelines in the PRISMA declaration of documents published between January 2015 and December 2020. The search took place between December 2020 and January 2021. Scielo, Pubmed, Medline, Scopus, WOS, CINHAL, LILACS, and Dialnet databases were consulted, and CASPe, AGREE, and HICPAC tools were used for the critical reading. A total of 52 studies were included to analyze nursing interventions for treatment and prevention. Nursing interventions to prevent phlebitis and ensure a proper catheter use included those related to the maintenance of intravenous therapy, asepsis, and choosing the dressing. With regard to the nursing interventions to treat phlebitis, these were focused on vigilance and caring and also on the use of medical treatment protocols. For the prevention of phlebitis, the highest rated evidence regarding asepsis include the topical use of >0.5% chlorhexidine preparation with 70% alcohol or 2% aqueous chlorhexidine, a proper hygienic hand washing, and the use clean gloves to handle connections and devices. Actions that promote the efficacy and safety of intravenous therapy include maintenance of venous access, infusion volume control, verification of signs of phlebitis during saline solution and medication administration, and constant monitoring. It is recommended to remove any catheter that is not essential. Once discharged from hospital, it will be necessary to warn the patient about signs of phlebitis after PVC removal.

Age-related blood biochemical changes (lipid metabolism) in healthy young and mature men living under the North conditions

2021 ◽  
Vol 66 (12) ◽  
pp. 728-732
Author(s):  
Inessa Vladislavovna Averyanova
Keyword(s):  
Lipid Metabolism ◽  
Cardiovascular Diseases ◽  
Lipid Profile ◽  
Metabolic Disorders ◽  
Age Groups ◽  
Photometric Method ◽  
The North ◽  
Blood Biochemical ◽  
Age Related ◽  
Younger Men

Metabolic disorders (dyslipidemias) are currently crucial since they develop cardiovascular diseases. The work was aimed at studying age dynamics and its correlation with severity of dyslipidemia in basic lipid metabolism variables (in different age groups). Materials and methods: Examinees were Caucasians born and permanently residing in Magadan region: 55 mature men and 147 young men (mean ages were 36.8±0.8 and 18.7±0.8 yr, respectively). Blood serum lipid metabolism was examined by colorimetric and photometric method using AU 680 (Beckman Coulter, USA). Results: The data of obtained lipidogram showed dependence of rise in all indicators on subjective older age with higher percentage of dyslipidemia and increase in calculated indices reflecting degree of the lipid profile atherogenicity. Conclusion: Overall, the North study revealed a safer lipid profile in group of younger men, while biochemical picture of older residents demonstrated increased values. Lipid atherogenicity is a very alarming factor in developing cardiovascular diseases, and a predictor of risks for metabolic syndrome.

scholarly journals MALIGNANT HYPERTHERMIA: CURRENT APPROACHES TO PREVENTION AND TREATMENT

2018 ◽  
Vol 2 (5) ◽  
pp. 154-158
Author(s):  
Евгений Ким ◽  
Evgenij Kim ◽  
Владимир Горбачев ◽  
Vladimir Gorbachev ◽  
Виталий Унжаков ◽  
...  
Keyword(s):  
Malignant Hyperthermia ◽  
Specific Treatment ◽  
Specific Drug ◽  
Disease Phenotype ◽  
Medical Assistance ◽  
Inhalation Anesthesia ◽  
Inhaled Anesthetics ◽  
Treatment And Prevention ◽  
Prevention And Treatment ◽  
The Russian Federation

One of the most serious complications of modern anesthesia is malignant hyperthermia, which is a pharmacogenetic disease phenotype manifested by skeletal muscle hypermetabolism and rhabdomyolysis during or after general anesthe- sia with the use of inhaled anesthetics and succinylcholine. In Russia, the problem of malignant hyperthermia remains unresolved. This is mainly due to the fact that the only specific drug dantrolene created for the effective treatment of malignant hyperthermia is still not legalized and thus formally prohibited to import, disseminate and apply on the domestic pharmaceutical market. This article deals with the regulatory framework of specific treatment of malignant hyperthermia in Russia, allowing the possibility to legally import to the territory of the Russian Federation dantrolene as an unregistered drug, if it is a question of rendering medical assistance on vital indications to a particular patient, or its unauthorized use for vital indications in a situation of extreme necessity. The article presents the recommendations of domestic experts on the treatment of malignant hyperthermia. In this case, as a possible alternative to dantrolene, magnesium preparations are considered, whose role in the treatment of the crisis of malignant hyperthermia continues to be specified. Thus, given the increasing use of inhalation anesthesia by Russian anesthetists, to ensure the safety of patients with regard to the development of malignant hyperthermia, it is possible only in the case of official registration in the do- mestic dantrolene market. Also, in the territory of Russia, a network of relevant consultative and diagnostic centers should be established. These measures will undoubtedly increase the effectiveness of treatment and prevention of severe consequences of this disease in our country.

On the importance of psychological factors in allergic diseases in children

1999 ◽  
Vol 80 (3) ◽  
pp. 219-221
Author(s):  
I. S. Aron ◽  
A. M. Potemkin
Keyword(s):  
Allergic Disease ◽  
Psychological Factors ◽  
Allergic Diseases ◽  
First Year ◽  
Childhood Diseases ◽  
Treatment And Prevention ◽  
Prevention And Treatment ◽  
First Year Of Life

Allergic diseases account for 20-25% in the overall structure of all morbidity in Russia [5]. The problem of prevention and treatment of allergic diseases in children is especially urgent, because allergic diseases occupy a leading place in the structure of childhood diseases. According to A.M. Potemkina, treatment and prevention of allergic diseases in children are most effective in the first three years of life. In children of the first year of life, monoallergy prevails, that is, one allergic disease (85%).

Abstract 5276: Sumoylation Of Klf5 Is A Molecular Switch Regulating Ppar-δ-containing Transcriptional Programs Of Lipid Metabolism

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Yumiko Oishi ◽  
Ichiro Manabe ◽  
Kazuyuki Tobe ◽  
Takashi Kadowaki ◽  
Ryozo Nagai
Keyword(s):  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Lipid Metabolism ◽  
Cardiovascular Diseases ◽  
Transcriptional Control ◽  
Uncoupling Protein ◽  
Molecular Switch ◽  
Atherosclerotic Cardiovascular Disease ◽  
Transcriptional Regulatory ◽  
Reporter Assays

Metabolic syndrome is increasingly recognized as a major risk factor for cardiovascular disease. We have previously shown that a zinc finger transcription factor, Krüppel-like factor 5 (KLF5), plays an important role in cardiovascular diseases, such as atherosclerosis and cardiac hypertrophy. Interestingly, KLF5 is also expressed in metabolic tissues, such as adipose tissue, skeletal muscle and pancreatic β-cells. Moreover, we found that KLF5 is crucial for adipocyte differentiation. Therefore, it is very likely that KLF5 plays multiple roles in development and progression of metabolic syndrome and its cardiovascular and metabolic consequences including atherosclerotic cardiovascular disease. Indeed, KLF5 heterozygous knockout ( KLF5 +/− ) mice were resistant to high-fat-induced obesity and metabolic syndrome, despite consuming more food than wild-type mice. This appears to in part reflect their enhanced energy expenditure. Expression of the genes involved in lipid oxidation and energy uncoupling, including uncoupling protein (UCP) and carnitine-palmitoyl transferase 1b (CPT1b) was upregulated in the soleus muscles of KLF5 +/− mice. KLF5 could be reversibly modified by small ubiquitin-like modifier 1 (SUMO1), after which SUMOylated KLF5 strongly inhibited CPT1b , UCP3 and UCP2 promoter activity. Results of chromatin immunoprecipitation, two-hybrid, and reporter assays showed that under basal conditions SUMOylated KLF5 associated with transcriptionally repressive regulatory complexes containing unliganded PPARδ and corepressors. However, upon agonist stimulation of PPARδ, the deSUMOylating enzyme was recruited and KLF5 was deSUMOylated. The unSUMOylated KLF5 now formed transactivating complexes with liganded PPARδ and CBP. Thus, SUMOylation appears to be a molecular switch affecting function of KLF5 and the transcriptional regulatory programs governing lipid metabolism. Moreover, KLF5 is essential for the PPARδ agonist-dependent transcriptional control. Results of the present study have established KLF5 as a novel key molecule in lipid metabolism and suggest that the posttranscriptional modification of KLF5 is an attractive novel therapeutic target for both metabolic and cardiovascular diseases.

Sign in / Sign up

Export Citation Format

Share Document